Radioactive drug tested in fight against tough cancers
NCT ID NCT05723640
Summary
This early-stage study tested the safety of a new radioactive drug called 177Lu-LNC1004 in adults with advanced solid tumors that have spread or returned. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers gave small groups of patients increasing doses to see how their bodies reacted.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, UNSPECIFIED, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National University Cancer Institute, Singapore National University Hospital, Singapore.
Singapore, 119077, Singapore
Conditions
Explore the condition pages connected to this study.